These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 19595154

  • 1. [Epidemiology of anticoagulation for hemodialysis patients: survey of 842 cases in seven hemodialysis centers].
    Sun XF, Xiao Q, Wang Y, Hao LR, Lin HL, Zhang ZM, Li JJ, Chen XM.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 10; 89(9):577-81. PubMed ID: 19595154
    [Abstract] [Full Text] [Related]

  • 2. [Appropriate dosage of unfraction heparin and low molecular weight heparin in hemodialysis patients].
    Xiao Q, Sun XF, Zhang D, Ma ZF, Wu MG, Wang H, Chen XM.
    Zhonghua Yi Xue Za Zhi; 2010 Jan 19; 90(3):187-91. PubMed ID: 20356555
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The use of enoxaparine for anticoagulation in extracorporeal circulation in hemodialysis at high risk for hemorrhage].
    Dechelette E, Pouzol P, Jurkovitz C, Kuentz F, Polack B, Cuzin E, Woler M.
    J Mal Vasc; 1987 Jan 19; 12 Suppl B():105-7. PubMed ID: 2834479
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The rationale for the use of low molecular weight heparin for hemodialysis treatments.
    Davenport A.
    Hemodial Int; 2013 Oct 19; 17 Suppl 1():S28-32. PubMed ID: 24134328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of anticoagulation on blood membrane interactions during hemodialysis.
    Hofbauer R, Moser D, Frass M, Oberbauer R, Kaye AD, Wagner O, Kapiotis S, Druml W.
    Kidney Int; 1999 Oct 19; 56(4):1578-83. PubMed ID: 10504511
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Present opinions concerning the administration of low molecular weight heparins in hemodialysis patients].
    Drozdz M, Kowalczyk-Michałek M, Kraśniak A, Sułowicz W.
    Przegl Lek; 2005 Oct 19; 62(4):257-9. PubMed ID: 16229247
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P, Dejagere T, Verhamme P, Claes K, Kuypers D, Bammens B, Vanrenterghem Y.
    Am J Kidney Dis; 2007 May 19; 49(5):642-9. PubMed ID: 17472846
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.